FDA Sets New Standards for Labels

The FDA released a new rule yesterday regarding the labeling of prescriptions and biological products which affect pregnancy, lactation and reproduction.

From the press release: “The final rule replaces the current product letter categories – A, B, C, D and X – used to classify the risks of using prescription drugs during pregnancy with three detailed subsections that describe risks within the real-world context of caring for pregnant women who may need medication.”

The new rule will go into effect by June 20, 2015.